2013
When Choosing Statin Therapy: The Case for Generics
Green JB, Ross JS, Jackevicius CA, Shah ND, Krumholz HM. When Choosing Statin Therapy: The Case for Generics. JAMA Internal Medicine 2013, 173: 229-232. PMID: 23303273, DOI: 10.1001/jamainternmed.2013.1529.Commentaries, Editorials and LettersMeSH KeywordsCardiovascular DiseasesChoice BehaviorDrugs, GenericDyslipidemiasEvidence-Based MedicineHumansHydroxymethylglutaryl-CoA Reductase InhibitorsTherapeutic Equivalency
2012
Avoidance of Generic Competition by Abbott Laboratories' Fenofibrate Franchise
Downing NS, Ross JS, Jackevicius CA, Krumholz HM. Avoidance of Generic Competition by Abbott Laboratories' Fenofibrate Franchise. JAMA Internal Medicine 2012, 172: 724-730. PMID: 22493409, PMCID: PMC3636774, DOI: 10.1001/archinternmed.2012.187.Commentaries, Editorials and LettersChemistry, PharmaceuticalDrugs, GenericFenofibrateHypolipidemic AgentsLaboratoriesMarketingTherapeutic Equivalency
2011
ACCF/AHA 2011 Health Policy Statement on Therapeutic Interchange and Substitution A Report of the American College of Cardiology Foundation Clinical Quality Committee
Holmes D, Becker J, Granger C, Limacher M, Page R, Sila C, Drozda J, Cacchione J, Erb B, Harrington R, Kennett J, Krumholz H, Masoudi F, Peterson E, Poppas A, Sahn D, Sanz M, Shahian D, Windle J, Wyman J. ACCF/AHA 2011 Health Policy Statement on Therapeutic Interchange and Substitution A Report of the American College of Cardiology Foundation Clinical Quality Committee. Journal Of The American College Of Cardiology 2011, 58: 1287-1307. PMID: 21849242, DOI: 10.1016/j.jacc.2011.06.001.Peer-Reviewed Original ResearchMeSH KeywordsBiological ProductsDrug SubstitutionDrugs, GenericHealth PolicyHumansTherapeutic EquivalencyUnited States